15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Qiagen NV, 4 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets span $36.00 to $54.00, a moderate spread. The average target of $42.89 sits 1% above the current $42.27. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.63 next quarter toward $2.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Hold
Strong Buy00%
Buy444%
Hold556%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Qiagen NV.
As of Jul, 4 of 9 firms rate QGEN a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
QGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.63
Range $0.61 – $0.64 · 9 analysts · -2% YoY
Next period, 9 analysts expect Qiagen NV to earn $0.63 a share (range $0.61 – $0.64), versus $0.64 a year earlier. Full-year consensus is $2.44, growing to $2.62 the year after.
REVENUE · NEXT QUARTER
$552.0M
Range $546.9M – $556.0M · 9 analysts · +4% YoY
Revenue is expected to reach $552.0M (range $546.9M – $556.0M), +3.6% year-over-year. Full-year consensus is $2.1B, rising to $2.3B next year.
Top analysts covering Qiagen NV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on QGEN.
#1
Luke Sergott
Barclays · Rank #194
Hold
$38.00-10.1% to target
Overall win rate
41%
+ Follow
#2
Patrick Donnelly
Citigroup · Rank #260
Hold
$38.00-10.1% to target
Overall win rate
32%
+ Follow
#3
CW
Casey Woodring
JP Morgan
Buy
No targeton QGEN
Coverage
—
+ Follow
#4
JK
Jan Koch
Deutsche Bank
Buy
No targeton QGEN
Coverage
—
+ Follow
#5
CS
Catherine Schulte
Baird
Buy
$43.00+1.7% to target
Coverage
—
+ Follow
QGEN stock forecast FAQ
What is QGEN's average 12-month price target?+
The 9 analysts with a live target average $42.89 for Qiagen NV over the next 12 months, ranging from a $54.00 high to a $36.00 low.
Is QGEN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 9 analyst ratings, 4 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for QGEN?+
The Street-high target is $54.00 (Deutsche Bank), and the Street-low is $36.00 (Stifel). The average of all 9 active targets is $42.89.
How many Wall Street analysts cover QGEN?+
9 analysts have an active rating on Qiagen NV, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering QGEN?+
Among analysts who currently cover QGEN, Luke Sergott of Barclays has the strongest overall Quantellect track record (Rank #194). Their current call is Hold with a $38.00 target.
What is Qiagen NV's projected EPS for next quarter?+
The consensus estimate is $0.63 per share (range $0.61 – $0.64) across 9 analysts. Full-year EPS is projected at $2.44, rising to $2.62 the following year.
How much revenue is Qiagen NV expected to report next quarter?+
Consensus revenue is $552.0M (range $546.9M – $556.0M). Full-year revenue is projected at $2.1B, growing to $2.3B next year.
Have analysts been upgrading or downgrading QGEN lately?+
As of Jul, 4 of 9 firms rate QGEN a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their QGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
